Compile Data Set for Download or QSAR
maximum 50k data
Found 126 with Last Name = 'harrison' and Initial = 'h'
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256265(CHEMBL4089486)
Affinity DataKi:  0.0600nMAssay Description:Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256283(CHEMBL4079711)
Affinity DataKi:  0.0700nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256264(CHEMBL4099333)
Affinity DataKi:  0.140nMAssay Description:Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasmaMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256277(CHEMBL4093698)
Affinity DataKi:  0.150nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256286(CHEMBL4076199)
Affinity DataKi:  0.210nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  0.25nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256260(CHEMBL4094403)
Affinity DataKi:  0.360nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256276(CHEMBL4079260)
Affinity DataKi:  0.390nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256284(CHEMBL4075544)
Affinity DataKi:  0.400nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256288(CHEMBL4085408)
Affinity DataKi:  0.440nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256283(CHEMBL4079711)
Affinity DataKi:  0.900nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256263(CHEMBL4088185)
Affinity DataKi:  1.30nMAssay Description:Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256277(CHEMBL4093698)
Affinity DataKi:  2nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256287(CHEMBL4105318)
Affinity DataKi:  2.10nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256284(CHEMBL4075544)
Affinity DataKi:  2.30nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256261(CHEMBL4059991)
Affinity DataKi:  3nMAssay Description:Inhibition of human plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256261(CHEMBL4059991)
Affinity DataKi:  3.40nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein(Sus scrofa)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256277(CHEMBL4093698)
Affinity DataKi:  3.60nMAssay Description:Inhibition of pig plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  5.5nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256276(CHEMBL4079260)
Affinity DataKi:  11nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein(Sus scrofa)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256276(CHEMBL4079260)
Affinity DataKi:  22nMAssay Description:Inhibition of pig plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Rattus norvegicus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256260(CHEMBL4094403)
Affinity DataKi:  30nMAssay Description:Inhibition of recombinant Sprague-Dawley rat plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins foll...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Mus musculus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  45nMAssay Description:Inhibition of recombinant mouse C-terminal 6His-tagged plasma kallikrein (20 to 638 residues) using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrat...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Mus musculus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256261(CHEMBL4059991)
Affinity DataKi:  54nMAssay Description:Inhibition of recombinant mouse C-terminal 6His-tagged plasma kallikrein (20 to 638 residues) using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrat...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasma kallikrein(Mus musculus)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256260(CHEMBL4094403)
Affinity DataKi:  120nMAssay Description:Inhibition of recombinant mouse C-terminal 6His-tagged plasma kallikrein (20 to 638 residues) using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrat...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein(Sus scrofa)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  300nMAssay Description:Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein(Sus scrofa)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256261(CHEMBL4059991)
Affinity DataKi:  410nMAssay Description:Inhibition of pig plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor XI(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  500nMAssay Description:Inhibition of human factor 11a using fluorogenic peptide as substrate by fluorescence based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein(Sus scrofa)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256260(CHEMBL4094403)
Affinity DataKi:  510nMAssay Description:Inhibition of pig plasma kallikrein using fluorogenic H-Pro-Phe-Arg-AMC peptide as substrate preincubated for 15 mins followed by substrate addition ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-5(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  800nMAssay Description:Inhibition of recombinant human C-terminal 10His-tagged KLK5 (67 to 293 residues) expressed in mouse NS0 cells using fluorogenic Boc-VPR-AMC peptide ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-13(Homo sapiens)
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  820nMAssay Description:Inhibition of platelet derived growth factor receptor beta phosphorylation in MG63 cells in the presence of human plasmaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16436(6,8-disulfanyloctanoic acid | D,L-Dihydrolipoic ac...)
Affinity DataKi:  950nM ΔG°:  -34.4kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1 [W220Y,C299A](Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16429(2,6-Dichlorophenylacetic acid | 2-(2,6-dichlorophe...)
Affinity DataKi:  1.00E+3nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256285(CHEMBL4086746)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibition of factor 11a (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16417((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic aci...)
Affinity DataKi:  1.50E+3nM ΔG°:  -33.2kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-14(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  2.00E+3nMAssay Description:Inhibition of recombinant human C-terminal 10His-tagged KLK14 (19 to 248 residues) expressed in mouse NS0 cells using fluorogenic Boc-VPR-AMC peptide...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16415((1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic...)
Affinity DataKi:  2.00E+3nM ΔG°:  -32.5kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16439(3-{[1-(carboxymethyl)-2,5-dioxopyrrolidin-3-yl]sul...)
Affinity DataKi:  2.30E+3nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16428(2,6-Difluorophenylacetic acid | 2-(2,6-difluorophe...)
Affinity DataKi:  2.50E+3nM ΔG°:  -32.0kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16426(2-(2-hydroxyphenyl)acetic acid | 2-Hydroxyphenylac...)
Affinity DataKi:  3.50E+3nM ΔG°:  -31.1kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16441((2S)-2-amino-4-{[(1R)-2-{[1-(carboxymethyl)-2,5-di...)
Affinity DataKi:  3.80E+3nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16429(2,6-Dichlorophenylacetic acid | 2-(2,6-dichlorophe...)
Affinity DataKi:  4.40E+3nM ΔG°:  -30.6kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16431(2-(naphthalen-2-yl)acetic acid | 2-Napthylacetic a...)
Affinity DataKi:  6.20E+3nM ΔG°:  -29.7kJ/molepH: 7.0 T: 2°CAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16440(2-{3-[(2-amino-3-methoxy-3-oxopropyl)sulfanyl]-2,5...)
Affinity DataKi:  6.50E+3nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1 [W220Y,C299A](Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16415((1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic...)
Affinity DataKi:  7.50E+3nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedMMDB

TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16437(2-{3-[(2-hydroxyethyl)sulfanyl]-2,5-dioxopyrrolidi...)
Affinity DataKi:  8.10E+3nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetKallikrein-2(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256262(CHEMBL4070056)
Affinity DataKi:  1.00E+4nMAssay Description:Inhibition of recombinant human C-terminal 10His-tagged KLK2 (1 to 261 residues) expressed in mouse NS0 cells using fluorogenic PFR-AMC peptide as su...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-2(Homo sapiens (Human))
Bicycle Therapeutics

Curated by ChEMBL
LigandPNGBDBM50256260(CHEMBL4094403)
Affinity DataKi:  1.00E+4nMAssay Description:Inhibition of recombinant human C-terminal 10His-tagged KLK2 (1 to 261 residues) expressed in mouse NS0 cells using fluorogenic PFR-AMC peptide as su...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1 [W220Y,C299A](Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16425(2-(2-bromophenyl)acetic acid | 2-Bromophenylacetic...)
Affinity DataKi:  1.10E+4nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member B1 [W220Y,C299A](Homo sapiens (Human))
Medical College of Wiscosin

LigandPNGBDBM16428(2,6-Difluorophenylacetic acid | 2-(2,6-difluorophe...)
Affinity DataKi:  1.20E+4nMAssay Description:The production of NADPH from NADP+ and benzyl alcohol and xylitol was monitored by an increase in NADPH fluorescence (ex: 340 nm; em: 460 nm) using a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 126 total ) | Next | Last >>
Jump to: